Journal
JOURNAL OF THEORETICAL BIOLOGY
Volume 537, Issue -, Pages -Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jtbi.2022.111029
Keywords
Viral dynamics; Time-dependent branching processes; Escape mutant; Drug resistance
Categories
Funding
- AMED Japan Program for Infectious Diseases Research [20wm0325007h0001, 20wm0325004s0201, 20wm0325012s0301, 20wm0325015s0301]
- Moonshot RD [JPMJMS2021, JPMJMS2025]
- JST MIRAI
Ask authors/readers for more resources
After infecting a host, a viral strain may rapidly increase and produce mutants with a faster proliferation rate than the original virus. However, most mutants become extinct due to the stochasticity caused by a small number of infected cells. The study calculated the fraction of mutants that could escape stochastic extinction based on a continuous-time branching process with a time-dependent growth rate.
After infecting a host, a viral strain may increase rapidly within the body and produce mutants with a faster proliferation rate than the virus itself. However, most of the mutants become extinct because of the stochasticity caused by the small number of infected cells. In addition, the mean growth rate of a mutant strain decreases with time because the number of susceptible target cells is reduced by the original strain. In this study, we calculated the fraction of mutants that can escape stochastic extinction, based on a continuous-time branching process with a time-dependent growth rate. We analyzed two cases differing in the mode of viral transmission: (1) an infected cell transmits the virus through cell to-cell contact with a susceptible target cell; (2) an infected cell releases numerous free viral particles that subsequently infect susceptible target cells. The chance for a mutant strain to be established decreases with time after infection of the original type, and it may oscillate before convergence at the stationary value. We then calculated the probability of escaping stochastic extinction for a drug-resistant mutant when a patient received an antiviral drug that suppressed the original strain. Combining the rate of mutant production from the original strain and the chance of escaping stochastic extinction, the number of emerging drug-resistant mutations may have two peaks: one soon after the infection of the original type and the second at the start of antiviral drug administration. (c) 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available